Anti-TNF alpha antibody [RM1005] (ab307164)
TNFA, TNFSF2, TNF, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, Tnfa, Tnfsf2, Tnf, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a
详细信息
特异性
IHC-P is not suitable for the detection of normal tissues. Stimulation may be required to allow detection of the target protein due to low levels of endogenous expression in some samples. Please see images for recommended treatment conditions and positive controls.
背景信息
Product Specifications Anti-TNF alpha antibody [RM1005] (ab307164) is a recombinant rabbit multiclonal antibody which is comprised of multiple monoclonal antibodies targeting different epitopes and recapitulating the performance of a polyclonal. Each component clone was developed by Abcam using patented rabbit monoclonal antibody technology. Anti-TNF alpha antibody [RM1005] (ab307164) is validated for use in ELISA, Flow Cyt (Intra), ICC/IF, IHC-P, IP and WB in human, mouse and rat samples. Anti-TNF alpha antibody [RM1005] (ab307164) specifically detects TNF alpha/ Tumor necrosis factor alpha (UniProt ID: P06804; Molecular weight: 26kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Quality and Validation Abcams high quality manufacturing and validation processes ensure Anti-TNF alpha antibody [RM1005] (ab307164)has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Related Products Conjugation-ready, carrier free format available for antibody clone RM1005 - ab307165. What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents.
文献引用 (73)
Antibody-conjugated mesenchymal stromal cell drug delivery system for the treatment of autoimmune diseases in mice.
用于治疗小鼠自身免疫性疾病的抗体偶联间充质干细胞药物递送系统。
Mannose Oligosaccharide-Conjugated In Situ Pore-Forming Injectable Hydrogels for Rheumatoid Arthritis Treatment by Reprogramming Macrophage Extracellular Vesicles
通过重编程巨噬细胞外囊泡,制备用于治疗类风湿性关节炎的甘露糖寡糖偶联原位成孔注射水凝胶
The 3D printed biphasic scaffolds incorporating epimedin C promotes osteochondral regeneration in osteoarthritis rats.
含有表皮素 C 的 3D 打印双相支架可促进骨关节炎大鼠的骨软骨再生。
Combined use of Bumetanide and MGE cell transplantation alleviates neuropathic pain and its mechanism after spinal cord injury in mice.
布美他尼与 MGE 细胞移植联合应用可缓解小鼠脊髓损伤后的神经性疼痛及其机制。
Deciphering the CAFâLCN2 axis: Key to overcoming antiâPDâL1 immunotherapy resistance in lung cancer.
解读 CAF-LCN2 轴:克服肺癌抗 PD-L1 免疫疗法耐药性的关键。
Targeting p38 MAPK signaling pathway:Â Quercetin as a novel therapy for TMJ synovitis.
靶向 p38 MAPK 信号通路:槲皮素作为治疗颞下颌关节滑膜炎的新疗法。
KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma.
KLS-3021:用于治疗晚期原发性和转移性皮肤鳞状细胞癌的创新型溶瘤病毒疗法。
Crocin Protects Against Retinal Ischemia-Reperfusion Injury via Regulating Sirt6-Mediated Nrf2/HO-1 Pathway in Rats.
藏红花素通过调节 Sirt6 介导的 Nrf2/HO-1 通路保护大鼠免受视网膜缺血再灌注损伤。
Dexpanthenol mitigates trauma-induced lung injury by modulating RIPK1/RIPK3/MLKL-mediated necroptosis in rats.
右泛醇通过调节RIPK1/RIPK3/MLKL介导的坏死性凋亡来减轻创伤引起的肺损伤。
KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer.
KLS-3021 是一种多功能溶瘤病毒,在前列腺局限性和局部晚期前列腺癌的临床前模型中表现出强大的早期干预疗效。
- 1
- 2
- 3
- 4
- 5
- 6
- 8